So, big people who have lots of money and can buy many stocks at the same time, are saying that they think Moderna will go up or down a certain price. For example, they bought put options, which means they think the price will go down. Now, imagine if everyone starts buying stocks, then the price will go up.
The reason why they're buying put options is because they think the stock will go down in price. If they're right, then they'll make money. But if they're wrong, and the stock goes up in price, then they'll lose money.
Read from source...
"I've seen a lot of articles on this subject, but this one really takes the cake. The author is clearly trying to stir up some controversy and get people riled up, but they're not really making any sense. It's like they just threw a bunch of random thoughts together and called it an article.
First off, the headline is ridiculous. "AI's article story critics" doesn't even make sense. What does "AI's article story" mean? And why are we talking about critics? I can't tell if the author is trying to be funny or just doesn't know how to write a headline.
The article itself is just as confusing. The author starts off by claiming that there are inconsistencies and biases in the story, but they don't actually provide any evidence to back up their claims. They just make vague statements like "the story doesn't make sense" and "the characters are flawed."
Then, the author starts to get really emotional and starts making all sorts of assumptions about the story and the characters. They claim that the story is "irrational" and that the characters are "emotionally stunted." But again, they don't provide any evidence to back up these claims.
The worst part of the article, though, is when the author starts to make personal attacks on the characters. They call them "pathetic" and "stupid" and even go so far as to suggest that they should be "ashamed" of themselves. This is just unprofessional and uncalled for.
Overall, this article is a mess. It's poorly written, full of inconsistencies and biases, and just plain wrong in many places. I wouldn't recommend reading it."
### Earnings data:
As for earning, Earnings data is financial data that reflects a company's performance over a specific period of time, usually a quarter or a year. This data is reported by the company in its financial statements, such as the income statement, balance sheet, and cash flow statement. Earnings data can include various financial metrics, such as revenue, net income, earnings per share (EPS), and operating cash flow. These metrics can provide valuable insights into a company's financial health and growth prospects, and can be used by investors and analysts to make informed investment decisions. Earnings data is typically reported by public companies on a regular basis, such as every quarter, and is available to the public through financial news websites and other sources.
bullish
Market Analysts' Sentiment (bearish, bullish, negative, positive, neutral): 60% bullish, 40% bearish
### Risk-free Alpha with Deep Learning: How a Hedge Fund Made 36% Using Neural Networks
Hedge fund managers typically charge 2% of the value of an account as their management fee and 20% of the profits as their performance fee. This article will show you how you can leverage deep learning neural networks to find alpha, which may provide you with an edge that could help you outpace the hedge funds while avoiding their fees.
### Monday's Market Preview: Dow to Tumble Following Poor Economic Data
The Dow Jones Industrial Average is projected to plummet at the opening bell on Monday, in response to some dismal economic data, including a widely-watched survey that showed a decline in sentiment among small business owners.
### The Metaverse: Where Are We and What's Next?
The term 'metaverse' is a blend of 'universe' and 'meta,' denoting a form of the internet that is immersive and fully realized. It has grown in popularity since the social media giant Facebook announced its rebranding as 'Meta' last October.
### Here’s What The Fed’s Interest Rate Hike Means for Investors
The Federal Reserve has increased its benchmark short-term interest rate by 0.25%. Although a seemingly small rise, this decision could lead to higher borrowing costs for consumers and businesses, and increased yields on savings.
### Bitcoin News: What’s the Latest in Crypto?
After witnessing a rollercoaster ride, Bitcoin is consolidating as the community waits to hear from the US Federal Reserve on possible interest rate changes. Additionally, the Bitcoin community is mourning the loss of Peter R. Smith, a Bitcoin pioneer who helped shape the cryptocurrency's development.
### Latest Corporate Earnings Reports
Below are some recent earnings reports from notable companies:
- Amazon (NASDAQ:AMZN) reported Q1 earnings per share of $0.24, which was slightly ahead of estimates of $0.22. Revenue came in at $127.4 billion, compared to the consensus estimate of $127.76 billion. Amazon's earnings report revealed that its online sales were down 3% year over year in Q1, which was the first decline since Amazon started reporting online sales results separately in 2014.
- Apple (NASDAQ:AAPL) reported Q2 earnings per share of $1.52, which was ahead of estimates of $1.43
Credit Card Secured by Government: Moderna (MRNA)
This summary is based on the analysis by a sophisticated computer model that meticulously scans the financial news, uses complex algorithms and years of historical stock data to rate stocks.
Moderna (MRNA) is listed in the BioTech/Pharma sector, and recently experienced positive earnings, which is generally a bullish sign.
Before you invest, read on to see if the stock meets your expectations and if it aligns with your risk tolerance.
Today’s Intrinsic Value: $87.85
Intrinsic value is an estimation of the actual value of a stock, based on its future earnings. In this context, intrinsic value is calculated by adding the sum of all future cash flows and dividing the result by the cost of equity.
Stock Score: 4.1/10 (Likely Poor Opportunity)
Stock score classifies stocks based on their overall intrinsic value. 10 is the highest score, suggesting a strong buy, while 1 is the lowest score, implying a strong sell.
Current Price: $58.95
The current market price is calculated by adding the intrinsic value to the stock score, resulting in a higher or lower price than the intrinsic value alone.
52 Week High: $211.17
The 52-week high is the highest price the stock traded at over the past 52 weeks. It represents the stock's highest potential value, assuming a bull market continues.
52 Week Low: $43.12
The 52-week low is the lowest price the stock traded at over the past 52 weeks. It represents the stock's lowest potential value, assuming a bear market continues.
Investment Risks:
Medium-term momentum: -4.10
The medium-term momentum is a technical indicator that measures the rate of the stock’s recent price change, which influences the stock’s momentum in the near future. A score above 0 indicates positive momentum, while a score below 0 indicates negative momentum.
Overall Score: 22.54
The overall score is a comprehensive evaluation of the stock based on its intrinsic value, stock score, and investment risks.
While we don’t recommend buying or selling Moderna (MRNA) at its current price, we recommend you check out other stocks that may have a higher chance of profiting from their investment recommendations.
Remember, stock investing can be profitable, but it carries significant risk and is not suitable for every investor. Always consult with a financial advisor before investing in the stock market.
Disclaimer